Nephron Sterile Compounding Center LLC logo

Regulatory Affairs Director

Nephron Sterile Compounding Center LLC

West Columbia, SCHybridPosted 33 days ago
Full TimeDirector & AboveRegulatory AffairsPharmaceutical
Original posting ↗

Summary

The Director, Regulatory Affairs and Device Quality Systems provides strategic and operational leadership for all regulatory and device-quality activities across Nephron's manufacturing divisions and affiliated entities. The role ensures end-to-end regulatory compliance, post-market vigilance, labeling governance, licensing maintenance, and quality-system oversight for medical devices and combination products. It encompasses regulatory and device/combination-product quality-system compliance under 21 CFR Part 820 (QMSR) and Part 4 (Combination Products), ISO 13485, and ISO 14971, while excluding direct oversight of drug-product cGMP quality systems (21 CFR Parts 210 and 211).

Job description

Job Purpose

The Director, Regulatory Affairs and Device Quality Systems provides strategic and operational leadership for all regulatory and device-quality activities across Nephron's manufacturing divisions and affiliated entities. The role ensures end-to-end regulatory compliance, post-market vigilance, labeling governance, licensing maintenance, and quality-system oversight for medical devices and combination products. It encompasses regulatory and device/combination-product quality-system compliance under 21 CFR Part 820 (QMSR) and Part 4 (Combination Products), ISO 13485, and ISO 14971, while excluding direct oversight of drug-product cGMP quality systems (21 CFR Parts 210 and 211).

Essential Duties and Responsibilities

  • Develop and communicate regulatory and device-quality strategies aligned with corporate objectives, risk tolerance, and product-portfolio growth plans
  • Lead U.S. and international regulatory strategy for drug, device, and combination-product portfolios (ANDA, 510(k), EUA, 503B, supplements, annual reports)
  • Oversee end-to-end management of regulatory submissions and dossiers, including ANDA and 503B applications, 510(k) notifications, and post-approval supplements (CBE-0, CBE-30, PAS), ensuring complete, accurate, and timely filings, deficiency responses, and annual report maintenance in accordance with FDA commitments
  • Serve as liaison to FDA and other health authorities, ensuring inspection readiness and timely responses to findings
  • Direct regulatory risk assessments, change-control impact evaluations, Field Alert Reports (FARs), recalls, and market-action decisions
  • Oversee device quality systems including design control, DHFs/DMRs, RMFs, risk management (ISO 14971), CAPA, and complaint investigations; ensuring ongoing alignment with evolving FDA Quality Management System Regulation (QMSR) and related ISO 13485 requirements
  • Lead labeling strategy and compliance governance across Rx, OTC, 503B, and device products, including Structured Product Labeling (SPL) submissions, content management, and change-control oversight
  • Direct pharmacovigilance and post-market safety activities, ensuring compliance with 21 CFR 314.80 and 803 requirements, including ADE, MDR, PADER, and MedWatch reporting, trend analysis, and cross-functional escalation of safety signals
  • Oversee licensing and establishment registrations (GDUFA, MDUFA, OMUFA, 503B) and ensure renewals occur on time to maintain market access
  • Maintain product listing and periodic regulatory reporting for drug, device, and 503B products, including SPL listings, 503B semi-annual reports, CARES Act drug-shortage reporting, and maintenance of accurate NDC, FEI, and product-code data across FDA systems
  • Manage product registration and market-access submissions for domestic and international markets, including End User Letters (EUL), import/export registrations, and related agency correspondence
  • Provide cross-departmental regulatory support to Quality Assurance, Operations, Supply Chain, R&D, and Business Development
  • Establish and monitor KPIs (submission timeliness, CAPA effectiveness, audit readiness, licensing renewals) and provide executive dashboards and Management Review inputs
  • Provide strategic input during business development, due diligence, and partnership evaluations regarding regulatory and quality-system maturity
  • Mentor and develop regulatory and device-quality staff; serve as SME during inspections, audits, and due diligence
  • Ensure governance and data integrity across regulatory and device-quality systems, including electronic submission, document control, and post market reporting platforms

While on-site presence is preferred, a hybrid work arrangement may be available depending on the candidate's experience and qualifications. Candidates should expect to be on-site for inspections, audits, and leadership meetings regardless of work arrangement.

Job Specifications and Qualifications

Knowledge & Skills

  • Proven experience leading ANDA, 510(k), and 503B submissions; direct FDA/ISO audit participation
  • Comprehensive understanding of 21 CFR Parts 4, 210/211, 820 (QMSR), ISO 13485, and 14971
  • Strong technical writing, analytical, and root-cause-investigation skills
  • Ability to translate regulatory requirements into actionable business processes and procedures
  • Leadership presence with the capacity to influence cross-functional teams and executive stakeholders
  • Exceptional organization, prioritization, and decision-making in fast-paced environments

Education/Experience

  • Doctorate-level candidates (PharmD, PhD, or equivalent): Typically, 7 years of pharmaceutical or medical-device industry experience, including 5 or more years of demonstrated capabilities in Regulatory Affairs or Quality Systems leadership
  • Master's or Bachelor's-level candidates: Typically, 12 years of industry experience with 7 or more years of direct Regulatory Affairs or Device Quality Systems responsibility
  • Equivalent combinations of advanced education, training, and demonstrated leadership may be considered

Working Conditions / Physical Requirements

  • Standard business hours, with flexibility to meet company needs
  • Occasional travel for regulatory meetings or audits

Requirements

  • Proven experience leading ANDA, 510(k), and 503B submissions
  • Direct FDA/ISO audit participation
  • Comprehensive understanding of 21 CFR Parts 4, 210/211, 820 (QMSR), ISO 13485, and 14971
  • Strong technical writing, analytical, and root-cause-investigation skills
  • Ability to translate regulatory requirements into actionable business processes and procedures
  • Leadership presence with capacity to influence cross-functional teams and executive stakeholders
  • Exceptional organization, prioritization, and decision-making in fast-paced environments
  • Doctorate-level candidates (PharmD, PhD, or equivalent): typically 7 years of pharmaceutical or medical-device industry experience, including 5 or more years in Regulatory Affairs or Quality Systems leadership
  • Master's or Bachelor's-level candidates: typically 12 years of industry experience with 7 or more years of direct Regulatory Affairs or Device Quality Systems responsibility

Company overview

Nephron Sterile Compounding Center LLC is a leading 503B outsourcing facility specializing in sterile pharmaceutical compounding and manufacturing. Based in West Columbia, South Carolina, the company operates as a registered outsourcing facility under Section 503B of the Federal Food, Drug, and Cosmetic Act, focusing on the production of sterile, preservative-free respiratory inhalation medications and other compounded drug products. The company serves a diverse customer base including hospitals, retail pharmacies, long-term care facilities, home care companies, and mail-order pharmacies. Nephron specializes in manufacturing generic respiratory medications used in the treatment of asthma and COPD, as well as producing sterile pre-filled medications, small-volume parenteral solutions, and IV bags. The facility utilizes advanced sterile manufacturing technologies and maintains cGMP-compliant operations with a high-purity water system capable of consistently providing Water for Injection. As an outsourcing facility, Nephron addresses drug shortages by manufacturing products in short supply, with capabilities including blow-fill-seal technology and aseptic processing. The company has faced regulatory scrutiny from the FDA regarding sterility assurance and compliance with 503B requirements, leading to voluntary recalls and ongoing compliance activities. Despite these challenges, Nephron remains a significant employer in the Lexington County area and continues to play a role in the sterile compounding pharmaceutical sector.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.